Abeona Therapeutics Inc. Stock News

4D Molecular Therapeutics (4DMT), a clinical-stage leader in the development of precision-guided AAV gene medicines based on directed evolution, today

Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene

Fox Corp. COO John Nallen confirmed the company is in “very, very early discussions” with the NFL about renewing its rights deal with the league, a closely watched process that he said …

4D Molecular Therapeutics (4DMT), a clinical-stage leader in the development of precision-guided AAV gene medicines based on directed evolution, annou

Advantage Oil & Gas Ltd. (TSE:AAV) (NYSE:AAV) Director Ronald A. Mcintosh purchased 15,000 shares of the company’s stock in a transaction on Monday, June 8th. The stock was bought at an average pric

When Astellas closed its $3 billion buyout of Audentes Therapeutics, the J.P. Morgan conference crowd was full of “backhanded congratulations.” They offered Natalie Holles, then the newly minted C

Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring, developing and commercializing high-potential

The

University of Florida researchers on Wednesday announced plans to repurpose a gene therapy approach used to treat rare neuromuscular diseases for a potential vaccine against COVID-19.

Repligen develops and sells bioprocessing technologies and systems involved in the manufacturing of biological drugs. The company operates within a high growth,

Hearing loss can stem from a variety of reasons, but in rare cases it’s caused by genetic defects. Akouos is developing a gene therapy to address these

Chinese technology firm EHang has developed a flying taxi called EHang 216, that could be ready to accept customers in just three years

Q1 2020 Abeona Therapeutics Inc Earnings Call